Aldeyra Therapeutics Inc (NASDAQ:ALDX) finished Friday with an addition of $0.42 to close at $6.68, an upside of 6.71 percent. An average of 833,840 shares of common stock have been traded in the last five days. There was a gain of $0.54 in the past week, and it reached a new high 37 times over the past 12 months. The last 20 days have seen an average of 574,020 shares traded, while the 50-day average volume stands at 547,556.
ALDX stock has decreased by -12.79% in the last month. The company shares reached their 1-month lowest point of $5.95 on 09/25/23. With the stock rallying to its 52-week high on 06/15/23, shares of the company touched a low of $4.95 and a high of $11.97 in 52 weeks. It has reached a new high 27 times so far this year and lost -4.02% or -$0.28 in price. In spite of this, the price is down -44.19% from the 52-week high.
Valuation Metrics
Aldeyra Therapeutics Inc (ALDX) stock’s beta is 1.11. Other valuation ratios to consider include the price-to-book (PB) ratio at 3.02.
Financial Health
The quick ratio of Aldeyra Therapeutics Inc for the three months ended June 29 was 9.79, and the current ratio was 9.79, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.08 and a total debt to equity ratio of 0.12 for the quarter ending June 29. Its gross profit as reported stood at $1.69 million compared to revenue of $62.68 million.
Earnings Surprise
For the three-month period that ended June 29, Aldeyra Therapeutics Inc had $10.13 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$8.99 million in the quarter, while revenues of -$15.62 million were shrunk -97.78%. The analyst consensus anticipated Aldeyra Therapeutics Inc’s latest quarter earnings to come in at -$0.31 per share, but it turned out to be -$0.15, a 51.60% surprise. For the quarter, EBITDA amounted to -$10.28 million. Shareholders own equity worth $58.6 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Aldeyra Therapeutics Inc (ALDX) price momentum. RSI 9-day as of the close on 29 September was 54.75%, suggesting the stock is Neutral, with historical volatility in this time frame at 39.43%.
As of today, ALDX’s price is $6.27 +8.79% or $0.54 from its 5-day moving average. ALDX is currently trading -10.46% lower than its 20-day SMA and -37.34% lower than its 100-day SMA. However, the stock’s current price level is -16.40% below the SMA50 and +7.40% above the SMA200.
The stochastic %K and %D were 27.21% and 18.37%, respectively, and the average true range (ATR) was 0.30. With the 14-day stochastic at 49.66% and the average true range at 0.30, the RSI (14) stands at 46.57%. The stock has reached 0.08 on the 9-day MACD Oscillator while the 14-day reading was at -0.11.
